-
-
-
-
-
-
-
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action - Hagens Berman
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
-
-
-
-
-
-
-
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
-
-
-
-
-
-
Stifel on Repligen (RGEN) M&A Speculation with Maravai (MRVI)
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

